Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China flag China · Delayed Price · Currency is CNY
31.52
+1.37 (4.54%)
Mar 10, 2026, 11:29 AM CST

Shenzhen Chipscreen Biosciences Company Description

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research and development of original small molecule drugs.

The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for the treatment of peripheral T-cell lymphoma and advanced hormone receptor-positive breast cancer; Chiglitazar Sodium, a PPAR pan-agonist for the treatment of metabolic diseases; and Chiauranib, a triple-pathway tumor-targeting inhibitor.

It is also developing CS23546, a small-molecule PD-L1 inhibitor; CS231295, a brain-penetrant Aurora B selective inhibitor; CS32582, a highly selective small-molecule allosteric inhibitor of tyrosine kinase 2; CS12088, a hepatitis B nucleocapsid assembly modulator; and CS12192 a highly selective JAK3 kinase inhibitor.

The company was founded in 2001 and is headquartered in Shenzhen, China.

Shenzhen Chipscreen Biosciences Co., Ltd.
Country China
Founded 2001
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 973
CEO Xian-Ping Lu

Contact Details

Address:
Zhigu Industrial Park
Shenzhen, 518057
China
Phone 86 755 2695 2070
Website chipscreen.com

Stock Details

Ticker Symbol 688321
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100003LW0
SIC Code 2834

Key Executives

Name Position
Dr. Xian-Ping Lu Founder, Chairman, GM, Chief Executive Officer and President
Jian-Xun Li BA.CFA Co-President, Head of Finance and Director
Dr. Desi Pan Vice President, Deputy GM, Chief Scientific Officer and Head of the Early Research and Development Center
Ou Hai Vice President, Deputy GM, Secretary of the Board, Head of Legal and Intellectual Property Department and Director
Dr. Zhi-Bin Li Ph.D. Senior Vice President and Head of Product Development and Production
Liangji She Senior Vice President and Head of the Commercial Segment
Dr. Leming Shi Co-Founder
Dr. Weiming Hu Co-Founder
Ji-Hui Yi MS Vice President of Sales and Marketing